Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-02-23

Clinical Trial Update: A Study To Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

View source ↗

Summary

Roche-sponsored observational study on treatment patterns and outcomes in patients with HER2-positive unresectable locally advanced or metastatic breast cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer, HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer | Status: WITHDRAWN